Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE

Drug Testing and Analysis

Volumn 5, Issue 11-12, 2013, Pages 870-876

  Desharnais, Philippe ^a   Naud, Jean François ^a   Ayotte, Christiane ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

2D electrophoresis; Desialylation; Doping control; Erythropoietin; SDS PAGE

Indexed keywords

BODY FLUIDS; CARBOXYLIC ACIDS; ELECTROPHORESIS;

2-D ELECTROPHORESIS; 2D-ELECTROPHORESIS; DESIALYLATION; DOPING CONTROL; ERYTHROPOIETIN; HUMAN ENDOGENOUS; ISOELECTRIC FOCUSING; NEURAMINIDASE; SDS-PAGE; SIALIC ACID MOIETY;

MOLECULAR WEIGHT;

CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; SIALIC ACID; SIALIDASE;

ARTICLE; CONTROLLED STUDY; DOPING; DRUG MICRODOSE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; HUMAN; ISOELECTRIC FOCUSING; MOLECULAR WEIGHT; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SIALYLATION; URINALYSIS;

2D ELECTROPHORESIS; DESIALYLATION; DOPING CONTROL; ERYTHROPOIETIN; SDS-PAGE;

CLOSTRIDIUM PERFRINGENS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROPOIETIN; HUMANS; ISOELECTRIC FOCUSING; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; SUBSTANCE ABUSE DETECTION;

EID: 84890806073     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1494     Document Type: Article

References (33)

1. W. Jelkmann Use of recombinant human erythropoietin as an antianemic and performance enhancing drug. Curr. Pharm. Biotechnol. 2000, 1, 11.
2. J.C. Egrie, T.W. Strickland, J. Lane, et al. Characterization and biological effects of recombinant human erythropoietin. Immunobiology 1986, 172, 213.
3. E. Tsuda, M. Goto, A. Murakami, et al. Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins. Biochemistry 1988, 27, 5646.
4. J.C. Egrie, J.R. Grant, D.K. Gillies, K.H. Aoki, T.W. Strickland The role of carbohydrate on the biological activity of erythropoietin. Glycoconj. J. 1993, 10, 263.
5. E. Grabenhorst, P. Schlenke, S. Pohl, M. Nimtz, H.S. Conradt Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells. Glycoconj. J. 1999, 16, 81.
6. C. Reichel The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design. Drug Test. Anal. 2011, 3, 883.
7. C.K. Kung, E. Goldwasser A probable conformation difference between recombinant and urinary erythropoietins. Proteins 1997, 28, 94.
8. World Antidoping Agency. WADA Technical Document TD2009EPO. Harmonization of the method for the identification of recombinant erythropoietins (i.e. epoetins) and analogues (e.g. darbepoetin and methoxypolyethylene glycol-epoetin beta). Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/Technical_Documents/WADA_TD2009EPO_Harmonization_of_Method_Identificiation_Recombinant_Erythropoietins_Analogues_EN.pdf [10 May 2013].
9. F. Lasne, L. Martin, J. de Ceaurriz Active urine and detection of recombinant erythropoietin, in Recent Advances in Doping Analysis (13), (Eds: W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck ), Sportverlag Strauss, Cologne, 2005, pp. 297.
10. V. Belalcazar, R. Guttierrez Gallego, E. Llop, J. Segura, J.A. Pascual Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine. Electrophoresis 2007, 27, 4387.
11. F. Lasne No doubt about the validity of the urine test for the detection of recombinant human erythropoietin. Blood 2006, 108, 1778.
12. P. Desharnais, C. Ayotte Towards the screening of urinary EPO by SDS-PAGE analysis, in Recent Advances in Doping Analysis (15), (Eds: W. Schanzer, H. Geyer, A. Gotzmann, E. Mareck ), Sportverlag Strauss, Cologne, 2007, pp. 303.
13. C. Reichel, R. Kulovics, V. Jordan, M. Watzinger, T. Geisendorfer SDS-PAGE of recombinant and endogenous erythropoietins: Benefits and limitations of the method for application in doping control. Drug Test. Anal. 2009, 1, 43.
14. M. Kohler, C. Ayotte, P. Desharnais, et al. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. Int. J. Sports Med. 2007, 29, 1.
15. P.E. Groleau, P. Desharnais, L. Côté, C. Ayotte Low LC-MS/MS detection of glycopeptides released from pmol levels of recombinant erythropoietin using nanoflow HPLC-chip electrospray ionization. J. Mass Spectrom. 2008, 43, 924.
16. F. Lasne, L. Martin, J.A. Martin, J. De Ceaurriz Isoelectric profiles of human erythropoietin are different in serum and urine. Int. J. Biol. Macromol. 2007, 41, 354.
17. F. Lasne, L. Martin, N. Crepin, J. de Ceaurriz Detection of isoelectric profiles of erythropoietin in urine: Differentiation of natural and administered hormones. Anal. Bioch. 2002, 311, 119.
18. F. Lasne Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. J. Immunol. Methods 2003, 276, 223.
19. I. Bajla, I. Hollander, M. Minichmayr, G. Gmeiner, C. Reichel GASepo, a software solution for quantitative analysis of digital images in EPO doping control. Comput. Methods Programs Biomed. 2005, 80, 246.
20. G. Stubiger, M. Marchetti, M. Nagano, C. Reichel, G. Gmeiner, G. Allmaier Characterization of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 19, 728.
21. V. Skibeli, G. Nissen-Lie, P. Torjesen Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 2001, 98, 3626.
22. J.C. Egrie, J.K. Browne Development and characterization of novel erythropoiesis stimulating protein (NESP). Brit. J. Cancer 2001, 84, 3.
23. E. Llop, RG. Gallego, V. Belalcazar, et al. Evaluation of protein N-glycosylation in 2-DE: Erythropoietin as a study case. Proteomics 2007, 7, 4278.
24. E. Llop, R. Guttierez Gallego, J. Segura, J. Mallorqui, J.A. Pascual Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo). Anal. Biochem. 2008, 383, 243.
25. H. Sasaki, B. Bothner, A. Dell, M. Fukuda Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J. Biol. Chem. 1987, 262, 12059.
26. M. Takeuchi, S. Takasaki, H. Miyazaki, et al. Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant chinese hamster ovary cells. J. Biol. Chem. 1988, 263, 3657.
27. M. Ashenden, M. Varlet-Marie, F. Lasne, M. Audran The effects of microdose recombinant human erythropoietin regimens in athletes. Haematologica 2006, 91, 1143.
28. T. Hamilton, D. Coyle The Secret Race: Inside the Hidden World of the Tour de France: Doping, Cover-ups, and Winning at All Costs. Random House Inc., New-York, 2012.
29. WADA. Harmonization of analysis and reporting of recombinant erythropoietins (i.e. epoetins) and analogues (e.g. darbepoetin, pegserpoetin, peginesatide, EPO-Fc) by electrophoretic techniques. Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/Technical_Documents/WADA-TD2013EPO-Harmonization-Analysis-of-Recombinant-Erythropoietins-EN.pdf [18 February 2013].
30. S. Lamon, L. Martin, N. Robinson, M. Saugy, J. de Ceaurriz, F. Lasne Effects of exercise on the isoelectric patterns of erythropoietin. Clin. J. Sport Med. 2009, 19, 311.
31. S. Voss, A. Ludke, S. Romberg, et al. Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin. Int. J. Sport Med. 2010, 31, 367.
32. A. Caldini, G. Moneti, A. Fanelli, et al. Epoetin-alpha, Epoetin beta and darbepoetin alfa: Two-dimensional gel electrophoresis isoforms characterization and mass spectrometry analysis. Proteomics 2003, 3, 937.
33. W. Schlags, B. Lachmann, M. Walther Two-dimensional electrophoresis of recombinant human erythropoietin: A future method for the European Pharmacopeia? Proteomics 2002, 2, 679.